Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World

Kamangar, Farin; Dores, Graça M.; Anderson, William F.

doi:10.1200/jco.2005.05.2308

Cited by 3,133 publications

(2,274 citation statements)

References 166 publications

Supporting

Mentioning

2,209

Contrasting

Unclassified

Order By: Relevance

“…In 2006, Kamangar et al 6 described the overall cancer incidence, mortality and prevalence of lung, breast, colon and rectum, stomach, prostate, liver, cervix and oesophageal cancer in selected geographic regions of the world using GLOBOCAN (2002) and five-continent databases from the IARC. The incidence rate of prostate cancer in North America (119.9/10 5 PY) was nearly 25.5 times higher than that of Asia (4.7/10 5 PY).…”

Section: The Difference In Prostate Cancer Incidence Rates Between Nomentioning

confidence: 99%

Prostate cancer: an emerging threat to the health of aging men in Asia

Zhang¹,

Yang²,

Zhang³

et al. 2011

Asian J Androl

View full text Add to dashboard Cite

To evaluate the early diagnosis and survival rates, the mortality-to-incidence rate ratio (MR/IR) was calculated from the IARC data. By comparing prostate cancer data between Asian men and North American men, we found that differences in the incidence rate and MR/IR could be attributed largely to a lack of annual prostate cancer screening with serum prostate-specific antigen (PSA) in most Asian countries. It is likely that PSA screening also contributes significantly to the differences in prostate cancer mortality rates. Prostate cancer has the highest incidence rate among five common malignancies in Asian Americans. However, the MR/IR ratio of prostate cancer is the lowest among cancers. These data seem to further support the usefulness of PSA screening, even though the percentage of low risk cancers is greater in prostate cancer than in other cancers. The low incidence rate of prostate cancer does not reflect the actual statistics of this disease in Asia. The data from limited institutions in many Asian countries seem to bias the true incidence and mortality rates. To improve this situation, incorporating PSA screening for prostate cancer, as well as constructing a nationwide cancer registration system, will be helpful.

show abstract

Section: The Difference In Prostate Cancer Incidence Rates Between Nomentioning

confidence: 99%

Prostate cancer: an emerging threat to the health of aging men in Asia

Zhang¹,

Yang²,

Zhang³

et al. 2011

Asian J Androl

View full text Add to dashboard Cite

show abstract

“…GC is still the second most common cause of cancer‐related death in developing countries 3, 4, 5, 6, 7, 8, 9, 10. The estimated new GC patients in United States in 2017 are 28 000 and estimated deaths are 10 960 11.…”

Section: Introductionmentioning

confidence: 99%

Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER‐based study

et al. 2018

View full text Add to dashboard Cite

The hematogenous metastatic pattern of gastric cancer (GC) was not fully explored. Here we analyzed the frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from GC patients. Data queried for this analysis included GC patients from the Surveillance, Epidemiology, and End Results Program database from 2010 to 2014. All of statistical analyses were performed using the Intercooled Stata 13.0 (Stata Corporation, College Station, TX). All statistical tests were two‐sided. Totally, there were 19 022 eligible patients for analysis. At the time of diagnosis, there were 7792 patients at stage IV, including 3218 (41.30%) patients with liver metastasis, 1126 (14.45%) with lung metastasis, 966 (12.40%) with bone metastasis and 151 (1.94%) with brain metastasis. GC patients with lung or liver metastasis have a higher risk of bone and brain metastasis than those without lung nor liver metastasis. Intestinal subtype had significantly higher rate of liver and lung metastasis, while diffuse type was more likely to have bone metastasis. Proximal stomach had significantly higher risk to develop metastasis than distal stomach. African‐Americans had the highest risk of liver metastasis and Caucasian had the highest prone to develop lung and brain metastasis. The median survival for patients with liver, lung, bone, and brain metastasis was 4 months, 3 months, 4 months and 3 months, respectively. It is important to evaluate the status of bone and brain metastasis in GC patients with lung or liver metastasis. Knowledge of metastatic patterns is helpful for clinicians to design personalized pretreatment imaging evaluation for GC patients.

show abstract

“…Breast cancer is one of the most common malignancies among women 1. Among them, triple‐negative breast cancer (TNBC) characterized by lacking expression of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor‐2 is extremely aggressive with a high risk of distant metastasis and early recurrence 2.…”

Section: Introductionmentioning

confidence: 99%

Periodic Mesoporous Organosilica Coated Prussian Blue for MR/PA Dual‐Modal Imaging‐Guided Photothermal‐Chemotherapy of Triple Negative Breast Cancer

Tian

et al. 2016

Advanced Science

View full text Add to dashboard Cite

Complete eradication of highly aggressive triple negative breast cancer (TNBC) remains a notable challenge today. In this work, an imaging‐guided photothermal‐chemotherapy strategy for TNBC is developed for the first time based on a periodic mesoporous organosilica (PMO) coated Prussian blue (PB@PMO) nanoplatform. The PB@PMOs have organic‐inorganic hybrid frameworks, uniform diameter (125 nm), high surface area (866 m2 g−1), large pore size (3.2 nm), excellent photothermal conversion capability, high drug loading capacity (260 µg mg−1), and magnetic resonance (MR) and photoacoustic (PA) imaging abilities. The MR and PA properties of the PB@PMOs are helpful for imaging the tumor and showing the accumulation of the nanoplatform in the tumor region. The bioluminescence intensity and tumor volume of the MDA‐MB‐231‐Luc tumor‐bearing mouse model demonstrate that TNBC can be effectively inhibited by the combined photothermal‐chemotherapy than monotherapy strategy. Histopathological analysis further reveals that the combination therapy results in most extensive apoptotic and necrotic cells in the tumor without inducing obvious side effect to major organs.

show abstract

Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World

Cited by 3,133 publications

References 166 publications

Prostate cancer: an emerging threat to the health of aging men in Asia

Prostate cancer: an emerging threat to the health of aging men in Asia

Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER‐based study

Periodic Mesoporous Organosilica Coated Prussian Blue for MR/PA Dual‐Modal Imaging‐Guided Photothermal‐Chemotherapy of Triple Negative Breast Cancer

Contact Info

Product

Resources

About